Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderik M Kortlever

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Senescence, wound healing and cancer: the PAI-1 connectionRoderik M Kortlever, René Bernards
Nature Cell Biology|July 25, 2006
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescenceRoderik M Kortlever, Paul J Higgins, René Bernards
The Journal of Biological Chemistry|July 11, 2008
Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activityRoderik M Kortlever, Jeroen H Nijwening, René Bernards
Molecular Cancer Research : MCR|August 30, 2008
Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signalingRoderik M Kortlever, Thijn R Brummelkamp, Laurens A van Meeteren, et al.
The Journal of Biological Chemistry|December 19, 2001
TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescenceThijn R Brummelkamp, Roderik M Kortlever, Merel Lingbeek, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modelingPeter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, et al.
Cell|December 2, 2017
Myc Cooperates with Ras by Programming Inflammation and Immune SuppressionRoderik M Kortlever, Nicole M Sodir, Catherine H Wilson, et al.
Nature Immunology|January 2, 2025
A stromal inflammasome Ras safeguard against Myc-driven lymphomagenesisAndrew Kent, Kristel Joy Yee Mon, Zachary Hutchins, et al.
Nature|November 26, 2010
Selective activation of p53-mediated tumour suppression in high-grade tumoursMelissa R Junttila, Anthony N Karnezis, Daniel Garcia, et al.
Cancer Cell|December 19, 2015
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast CancerBjörn von Eyss, Laura A Jaenicke, Roderik M Kortlever, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Senescence, wound healing and cancer: the PAI-1 connectionRoderik M Kortlever, René Bernards
Nature Cell Biology|July 25, 2006
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescenceRoderik M Kortlever, Paul J Higgins, René Bernards
The Journal of Biological Chemistry|July 11, 2008
Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activityRoderik M Kortlever, Jeroen H Nijwening, René Bernards
Molecular Cancer Research : MCR|August 30, 2008
Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signalingRoderik M Kortlever, Thijn R Brummelkamp, Laurens A van Meeteren, et al.
The Journal of Biological Chemistry|December 19, 2001
TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescenceThijn R Brummelkamp, Roderik M Kortlever, Merel Lingbeek, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modelingPeter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, et al.
Cell|December 2, 2017
Myc Cooperates with Ras by Programming Inflammation and Immune SuppressionRoderik M Kortlever, Nicole M Sodir, Catherine H Wilson, et al.
Nature Immunology|January 2, 2025
A stromal inflammasome Ras safeguard against Myc-driven lymphomagenesisAndrew Kent, Kristel Joy Yee Mon, Zachary Hutchins, et al.
Nature|November 26, 2010
Selective activation of p53-mediated tumour suppression in high-grade tumoursMelissa R Junttila, Anthony N Karnezis, Daniel Garcia, et al.
Cancer Cell|December 19, 2015
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast CancerBjörn von Eyss, Laura A Jaenicke, Roderik M Kortlever, et al.
Pageof 2